Investigating the effect of informing about the management of the chemotherapy side effects with the help of artificial intelligence tool

Comparison the impact of informing about the management of chemotherapy side effects with the help of an artificial intelligence tool with phone support in breast cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240206060919N1

Enrollment

Registered

2024-04-18

Start date

2024-08-05

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

side effects of chemotherapy drugs in patients with breast cancer. Cancer chemotherapy drug regimen, adverse effect in therapeutic use

Interventions

Intervention 1: First intervention group: Smart nurse users group for getting information about chemotherapy side effects management, The collected information about how to manage the side effects of

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: breast cancer patients who have received chemotherapy breast cancer patients who have a high school education or higher literacy level breast cancer patients who want to enter the study breast cancer patients who have the ability to work with computer and the Internet

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The percentage of self-efficacy of breast cancer patients in managing the side effects of chemotherapy drugs. Timepoint: 6 months after the beginning of the intervention. Method of measurement: symptom-management’s self-efficacy scale-breast cancer (SMSES-BC) questionnaire.	—

Secondary

Measure	Time frame
The level of anxiety about the side effects of chemotherapy drugs. Timepoint: 6 months after the intervention. Method of measurement: A global measure of perceived stress by Cohen.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShiva Shirani bidabadi

Esfahan University of Medical Sciences

shivashirani@res.mui.ac.ir+98 31 3237 1103

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026